- CHILDREN'S HEALTH DEFENSE - Brownstone Institute -By Dr. Yaakov Ophir - APRIL 11, 2023 -
In their new article in the Journal of American Physicians and Surgeons, Drs. Yaffa Shir-Raz, Shay Zakov, Peter McCullough and Yaakov Ophir dissect the claim that COVID-19 boosters are capable of providing long-term protection against severe illness and deaths.
Two key bricks seem to have already fallen from the COVID-19 vaccines’ narrative — the one about their fantastic efficacy against infections and the one about their superb safety.
However, one stubborn narrative brick seems to stand still, leading many people to believe that the booster doses of the vaccines are capable of providing long-term protection against severe illness and deaths (despite their failure to protect against infections).
But is this brick really that strong?
Does the existing scientific literature really support the notion that the two types of protection are independent of each other — that the protection against severe illness and deaths somehow remained high while the protection against infections disappeared?
In our new article in the Journal of American Physicians and Surgeons, Dr. Yaffa Shir-Raz, Dr. Shay Zakov, Dr. Peter McCullough and myself aimed to answer these questions from a purely scientific point of view.
We conducted a rigorous review of representative data from three types of sources: (1) the original clinical trials by Pfizer and Moderna, (2) the more contemporary studies on the fourth dose of the vaccine and (3) the popular dashboards of pandemic statistics.
In this relatively short article (that echoes a video I prepared on this topic), I will not be able to present our entire findings. However, I do wish to give you a taste of our review using three examples, starting with the founding clinical trial by Pfizer.
Number of deaths in the clinical trial by Pfizer
One might (falsely) assume that the key question I presented above was already answered in the Phase 3, Randomized Control Trial by Pfizer — the one that allowed the U.S. Food and Drug Administration (FDA) to issue its emergency authorization to use the COVID-19 vaccines.
After all, randomized controlled trials are considered to be the gold standard in biomedical research. Nevertheless, this key clinical trial did not really teach us anything about the ability of the vaccines to protect against severe illness and death.